Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis.

Mateus Trinconi CunhaMariana Carvalho GouveiaFelippe Lazar NetoLaura TestaPaulo Marcelo HoffEvandro de AzambujaRenata Colombo Bonadio

Published in: British journal of cancer (2023)

Results show that nIO combined with chemotherapy can provide significant EFS and OS benefits, supporting its use as standard treatment for early-stage TNBC.

Keyphrases

early stage
locally advanced
systematic review
rectal cancer
sentinel lymph node
neoadjuvant chemotherapy
clinical trial
squamous cell carcinoma
case report
study protocol
meta analyses
radiation therapy
electronic health record
phase iii
big data
phase ii
combination therapy
open label
replacement therapy